Promising Molecular Targets and Biomarkers for Male BPH and LUTS

作者：Gharaee Kermani Mehrnaz; Macoska Jill A^*

来源：Current Urology Reports, 2013, 14(6): 628-637.

DOI：10.1007/s11934-013-0368-z

• Benign prostate hyperplasia
• Biomarkers
• Collagen
• Fibrosis
• Inflammation
• Lower urinary tract symptoms
• Molecular targets
• Myofibroblast
• Novel therapeutic intervention

Benign prostatic hyperplasia (BPH) is a major health concern for aging men. BPH is associated with urinary voiding dysfunction and lower urinary tract symptoms (LUTS), which negatively affects quality of life. Surgical resection and medical approaches have proven effective for improving urinary flow and relieving LUTS but are not effective for all men and can produce adverse effects that require termination of the therapeutic regimen. Thus, there is a need to explore other therapeutic targets to treat BPH/LUTS. Complicating the treatment of BPH/LUTS is the lack of biomarkers to effectively identify pathobiologies contributing to BPH/LUTS or to gauge successful response to therapy. This review will briefly discuss current knowledge and will highlight new studies that illuminate the pathobiologies contributing to BPH/LUTS, potential new therapeutic strategies for successfully treating BPH/LUTS, and new approaches for better defining these pathobiologies and response to therapeutics through the development of biomarkers and phenotyping strategies.

• 出版日期2013-12